Effect of efalizumab on neutrophil and monocyte functions in patients with psoriasis

International Journal of Immunopathology and Pharmacology

Volumn 21, Issue 2, 2008, Pages 437-445

  Capsoni, Franco ^a   Ongari, A M ^a   Frigerio, E ^a   Taglioni, M ^a   Altomare, G F ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Chemotactic activity; Efalizumab; Monocyte; Neutrophil; Plaque psoriasis

Indexed keywords

ANTIGEN; CD11B ANTIGEN; CD128A ANTIGEN; CD128B ANTIGEN; CHEMOATTRACTANT; CYTOKINE; EFALIZUMAB; INTERLEUKIN 1BETA; INTERLEUKIN 8; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; OXYGEN RADICAL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; CELL COUNT; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MONOCYTE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PSORIASIS; RESPIRATORY BURST; TREATMENT RESPONSE;

EID: 47249157635     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200802100224     Document Type: Article

References (26)

1. Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005; 64:30-6.
2. Smith CH, Anstey AV, Barker JN, Burden AD, Chalmers RJ, Chandler D, Finlay AY, Griffiths CE, Jackson K, McHugh NJ, McKenna KE, Reynolds NJ, Ormerod AD on behalf of the British Association of Dermatologists. British Association of Dermatologists: guidelines for use of biological interventions in psoriasis Br J Dermatol 2005; 153:486-97.
3. Sterry W, Barker J, Boehncke WH et al. Biological therapies in the systemic management of psoriasis: International Consensus Conference. Br J Dermatol 2004; 151(S):3-17.
4. Krueger GG, Papp KA, Stough DB, Lóven KH, Gulliver WP, Ellis CN, for the Alefacept Clinical Study Group. A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. J Am Acad Dermatol 2002; 47:821-33.
5. Gottlieb AB, Evans R, Li S, Dooley LT, Guzzo CA, Baker D, Bala M, Marano CW, Menter A. Infliximab induction therapy for patients with severe plaque-type psoriasis - a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 2004; 51:534-42.
6. Leonardi CL, Powers JL, Matheson RT, Goffe BF, Zitnik R, Wang A, Gottlieb AB, for the Etanercept Psoriasis Study Group. Etanercept as monotherapy in patients with psoriasis. N Engl J Med 2003; 349:2014-22.
7. Lebwohl M, Tyring SK, Hamilton TK, Toth D, Glazer S, Tawfik NH, Walicke P, Dummer W, Wang X, Garovoy MR, Pariser D, for the Efalizumab Study Group. A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. N Engl J Med 2003; 349:2004-13.
8. Gordon KB, Papp KA, Hamilton TK, Walicke PA, Dummer W, Li N, Bresnahan BW, Menter A, for the Efalizumab Study Group. Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial. JAMA 2003; 290:3073-80.
9. Leonardi CL, Papp KA, Gordon KB, Menter A, Feldman SR, Caro I, Walicke PA, Compton GP, Gottlieb AB, for the Efalizumab Study Group. Extended efalizumab therapy improves chronic plaque psoriasis: Results from a randomized phase III trial. J Am Acad Dermatol 2005; 52:425-33.
10. Selenko-Gebauer N, Karlhofer F, Stingl G. Efalizumab in routine use: a clinical experience. Br J Dermatol 2007; 156(S):1-6.
11. Mortensen DL, Walicke PA, Wang X, Kwon P, Kuebler P, Gottlieb AB, Krueger JG, Leonardi C, Miller B, Joshi A. Pharmacokinetics and pharmacodynamics of multiple weekly subcutaneous efalizumab doses in patients with plaque psoriasis. J Clin Pharmacol 2005; 45:286-98.
12. Stratis A, Pasparakis M, Rupee RA, Markur D, Hartmann K, Scharffetter-Kochanek K, Peters T, van Rooijen N, Krieg T, Haase I. Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. J Clin Invest 2006; 116:2094-104.
13. Wang H, Peters T, Kess D, Sindrilaru A, Oreshkova T, Van Rooijen N, Stratis A, Renkl AC, Sunderkötter C, Wlaschek M, Haase I, Scharffetter-Kochanek K. Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J Clin Invest 2006; 116:2105-14.
14. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157:238-44.
15. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. J Lab Clin Invest 1968; 21:77-89.
16. Boyum A. Isolation of human monocytes with Nycodenz a new non-ionic iodinated gradient medium. Scand J Immunol 1983; 17:429-36.
17. Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J Exp Med 1962; 115:453-66.
18. Capsoni F, Sarzi-Puttini P, Atzeni F, Minonzio F, Bonara P, Doria A, Carrabba M. Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis. Arthritis Res Ther 2005; 7:250-5.
19. Minkenberg I, Ferber E. Lucigenin-dependent chemiluminescence as a new assay for NAD(P)H-oxidase activity in particulate fractions of human polymorphonuclear leukocytes. J Immunol Methods 1984; 71:61-7.
20. Socinski MA, Cannistra SA, Sullivan R, Elias A, Antman K, Schnipper L, Griffin JD. Granulocyte-macrophage colony-stimulating factor induces the expression of the CD11b surface adhesion molecule on human granulocytes in vivo. Blood 1988; 72:691-7.
21. Catania A, Garofalo L, Cutuli MG, Gringeri A, Santagostino E, Lipton JM. Melanocortin peptides inhibit production of proinflammatory cytokines in blood of HIV-infected patients. Peptides 1998; 19:1099-104.
22. Henderson RB, Lim LH, Tessier PA, Gavins FN, Mathies M, Perretti M, Hogg N. The use of lymphocyte function-associated antigen (LFA)-1-deficient mice to determine the role of LFA-1, Mac-1, and alpha4 integrin in the inflammatory response of neutrophils. J Exp Med 2001; 194:219-26.
23. Lu H, Smith CW, Perrard J, Bullard D, Tang L, Shappell SB, Entman ML, Beaudet AL, Ballantyne CM. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice. J Clin Invest 1997; 99:1340-50.
24. Green CE, Schaff UY, Sarantos MR, Lum AFH, Staunton DE, Simon SI. Dynamic shifts in LFA-1 affinity regulate neutrophil rolling, arrest, and transmigration on inflamed endothelium. Blood 2006; 107:2101-11.
25. Schön M, Denzer D, Kubitza RC, Ruzicka T, Schön MP. Critical role of neutrophils for the generation of psoriasiform skin lesions in flaky skin mice. J Invest Dermatol 2000; 114:976-83.
26. Terui T, Ozawa M, Tagami H. Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop. Exp Dermatol 2000; 9:1-10.